Sandra Merkel Dejames PhD

Dr. Merkel DeJames is Vice President of Precision Medicine at Metabolon, the pioneer and leading health technology company in metabolomics. She has international business experience across several industries, including pharmaceuticals, diagnostics, agriculture, energy and life sciences, and has broad experience in biotechnology, including direct research, early stage commercialization and new technology development. Prior to Metabolon, Dr. Merkel DeJames was Head of Regional Development (Americas Region) for Novozymes,leading market strategy development and global commercialization for new products and technologies across multiple industries. While there, she also played a key role in developing a novel therapeutic cell-based technology to address next-generation market needs. Dr. Merkel DeJames serves on various boards and advisory councils,including the National Advisory Board for the NCSU Institute for EmergingIssues and the North Carolina Center of Innovation Networks, and is Co-founder and Board Chair for NC Elite Volleyball Inc., an organization focused on the development of student-athletes. She holds a Ph.D. in Biology and completed her post-doctoral training at the UNC School of Medicine.